Drug Type Personalized antigen vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Endometrial Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Advanced Triple-Negative Breast Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Cervical Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Gastric Adenocarcinoma | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Hepatocellular Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | US | 31 Mar 2022 | |
Locally Advanced Melanoma | Phase 2 | US | 31 Mar 2022 |